| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13171* | 2021 |
| Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder PI Karakiewicz, S Benayoun, C Zippe, G Lüdecke, H Boman, ... BJU international 97 (5), 997-1001, 2006 | 197 | 2006 |
| Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder SF Shariat, C Zippe, G LüDECKE, H Boman, M Sanchez-Carbayo, ... The Journal of urology 173 (5), 1518-1525, 2005 | 189 | 2005 |
| Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine S Eissa, R Ali-Labib, M Swellam, M Bassiony, F Tash, TM El-Zayat European urology 52 (5), 1388-1397, 2007 | 134 | 2007 |
| Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer SF Shariat, MJ Marberger, Y Lotan, M Sanchez-Carbayo, C Zippe, ... The Journal of urology 176 (3), 919-926, 2006 | 127 | 2006 |
| Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease S Eissa, M Matboli, R Aboushahba, MM Bekhet, Y Soliman Journal of Diabetes and its Complications 30 (8), 1585-1592, 2016 | 116 | 2016 |
| Clinical verification of a novel urinary microRNA panal: 133b,-342 and-30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis S Eissa, M Matboli, MM Bekhet Biomedicine & Pharmacotherapy 83, 92-99, 2016 | 108 | 2016 |
| Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors S Eissa, M Swellam, M Sadek, M Sherif Mourad, OEL Ahmady, A Khalifa The Journal of urology 168 (2), 465-469, 2002 | 105 | 2002 |
| Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs S Eissa, SK Kassim, RA Labib, IM El‐Khouly, TM Ghaffer, M Sadek, ... Cancer 103 (7), 1356-1362, 2005 | 87 | 2005 |
| Caffeic acid attenuates diabetic kidney disease via modulation of autophagy in a high-fat diet/streptozotocin-induced diabetic rat M Matboli, S Eissa, D Ibrahim, MGA Hegazy, SS Imam, EK Habib Scientific Reports 7 (1), 2263, 2017 | 86 | 2017 |
| Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer AI Nossier, S Eissa, MF Ismail, MA Hamdy, HMES Azzazy Biosensors and Bioelectronics 54, 7-14, 2014 | 80 | 2014 |
| Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry S Eissa, LS Seada Clinical Chemistry 44 (7), 1423-1429, 1998 | 76 | 1998 |
| Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis S Eissa, M Matboli, NOE Essawy, YM Kotb Tumor Biology 36, 9545-9552, 2015 | 62 | 2015 |
| Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer S Eissa, M Swellam, R Ali-Labib, A Mansour, O El-Malt, FM Tash The Journal of urology 178 (3), 1068-1072, 2007 | 58 | 2007 |
| Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers S Eissa, S Kassim, O El-Ahmady Current Opinion in Obstetrics and Gynecology 15 (5), 395-403, 2003 | 58 | 2003 |
| Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer. S Eissa, A Khalifa, A El-Gharib, N Salah, MK Mohamed Anticancer research 17 (4B), 3091-3097, 1997 | 55 | 1997 |
| Expression of HYAL1 and Survivin RNA as Diagnostic Molecular Markers for Bladder Cancer S Eissa, M Swellam, H Shehata, IM El-Khouly, T El-Zayat, O El-Ahmady The Journal of urology 183 (2), 493-498, 2010 | 53 | 2010 |
| Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer S Eissa, SF Zohny, M Swellam, MH Mahmoud, TM El-Zayat, AM Salem Clinical Biochemistry 41 (16-17), 1335-1341, 2008 | 52 | 2008 |
| HER2/neu expression in bladder cancer: relationship to cell cycle kinetics S Eissa, HS Ali, AH Al Tonsi, A Zaglol, O El Ahmady Clinical biochemistry 38 (2), 142-148, 2005 | 51 | 2005 |
| Aberrant Methylation of RARβ2 and APC Genes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer S Eissa, M Swellam, IM El-Khouly, SK Kassim, H Shehata, A Mansour, ... Cancer epidemiology, biomarkers & prevention 20 (8), 1657-1664, 2011 | 49 | 2011 |
